{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T12:11:35Z","timestamp":1794053495678,"version":"4.8.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.biopha.2022.113089","type":"journal-article","created":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T10:12:17Z","timestamp":1652004737000},"page":"113089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"special_numbering":"C","title":["COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality"],"prefix":"10.1016","volume":"151","author":[{"given":"Prateek","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan","family":"Behl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhbir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajmer Singh","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Albarrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Albratty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulkarim M.","family":"Meraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bungau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113089_bib1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4239\/wjd.v3.i6.110","article-title":"Trends in prevalence of diabetes in Asian countries","volume":"3","author":"Ramachandran","year":"2012","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.biopha.2022.113089_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res Clin. Pr."},{"key":"10.1016\/j.biopha.2022.113089_bib3","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.2174\/1381612826666200414163148","article-title":"Recent developments in medicinal chemistry of allosteric activators of human glucokinase for type 2 diabetes mellitus therapeutics","volume":"26","author":"Grewal","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2022.113089_bib4","article-title":"Novel and emerging therapeutic drug targets for management of type 2 diabetes mellitus","volume":"24","author":"Sharma","year":"2021","journal-title":"Obes. Med."},{"key":"10.1016\/j.biopha.2022.113089_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2174\/1389557514666140722082713","article-title":"Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus","volume":"14","author":"Grewal","year":"2014","journal-title":"Mini Rev. Med Chem."},{"key":"10.1016\/j.biopha.2022.113089_bib6","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1046\/j.1440-1843.2003.00518.x","article-title":"SARS: epidemiology","volume":"8","author":"Chan-Yeung","year":"2003","journal-title":"Respirology"},{"key":"10.1016\/j.biopha.2022.113089_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol"},{"key":"10.1016\/j.biopha.2022.113089_bib8","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.biopha.2022.113089_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","volume":"63","author":"Xu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.biopha.2022.113089_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-5793(02)03640-2","article-title":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme","volume":"532","author":"Harmer","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2022.113089_bib11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/jmv.25824","article-title":"Response to Commentary on \u201cThe neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients\u201d","volume":"92","author":"Li","year":"2020","journal-title":"J. Med Virol."},{"key":"10.1016\/j.biopha.2022.113089_bib12","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/nm1007-1142b","article-title":"Not so fast: adaptive suppression of innate immunity","volume":"13","author":"Palm","year":"2007","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2022.113089_bib13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.113089_bib14","first-page":"1","article-title":"The clinical characteristics and outcomes of COVID-19 infections in patients with diabetes at a tertiary care center in the UAE","volume":"26","author":"Hafidh","year":"2021","journal-title":"Dubai Diabetes Endocrinol. J."},{"key":"10.1016\/j.biopha.2022.113089_bib15","first-page":"1897","article-title":"Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19","volume":"22","author":"Li","year":"2020","journal-title":"Diabetes ObesMetab"},{"key":"10.1016\/j.biopha.2022.113089_bib16","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-8587(20)30272-2","article-title":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study","volume":"8","author":"Barron","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.biopha.2022.113089_bib17","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.2337\/dc20-0598","article-title":"Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study","volume":"43","author":"Shi","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.113089_bib18","doi-asserted-by":"crossref","unstructured":"N. Holman, P. Knighton, P. Kar, J. O'Keefe, M. Curley, A. Weaver, E. Barron, C. Bakhai, K. Khunti, N.J. Wareham, N. Sattar, B. Young, J. Valabhji, Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study, Lancet Diabetes Endocrinol 8:823\u2013833. https:\/\/doi.org\/10.1016\/S2213\u20138587(20)30271\u20130.","DOI":"10.1016\/S2213-8587(20)30271-0"},{"key":"10.1016\/j.biopha.2022.113089_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.113089_bib20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.113089_bib21","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1056\/NEJMoa030666","article-title":"A cluster of cases of severe acute respiratory syndrome in Hong Kong","volume":"348","author":"Tsang","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2022.113089_bib22","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S1473-3099(13)70204-4","article-title":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","volume":"13","author":"Assiri","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.biopha.2022.113089_bib23","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges","volume":"55","author":"Lai","year":"2019","journal-title":"Int J. Antimicrob. Agents"},{"key":"10.1016\/j.biopha.2022.113089_bib24","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41591-020-0817-4","article-title":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding","volume":"26","author":"Xu","year":"2020","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2022.113089_bib25","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2020.2565","article-title":"Presumed asymptomatic carrier transmission of COVID-19","volume":"323","author":"Bai","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2022.113089_bib26","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.113089_bib27","doi-asserted-by":"crossref","first-page":"W94","DOI":"10.1097\/RTI.0000000000000506","article-title":"A diabetic patient with 2019-nCoV (COVID-19) infection who recovered and was discharged from hospital","volume":"35","author":"Han","year":"2020","journal-title":"J. Thorac. Imaging"},{"key":"10.1016\/j.biopha.2022.113089_bib28","article-title":"All feet on deck-the role of podiatry during the COVID-19 pandemic: preventing hospitalizations in an overburdened healthcare system, reducing amputation and death in people with diabetes","author":"Rogers","year":"2020","journal-title":"J. Am. Podiatr. Med Assoc."},{"key":"10.1016\/j.biopha.2022.113089_bib29","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.12669\/pjms.36.COVID19-S4.2638","article-title":"Coronavirus Disease 2019 (COVID-19) Pandemic and Economic Impact","volume":"36","author":"Ahmad","year":"2020","journal-title":"Pak. J. Med Sci."},{"key":"10.1016\/j.biopha.2022.113089_bib30","article-title":"Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach","volume":"1866","author":"Naqvi","year":"2020","journal-title":"Biochim. Acta Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2022.113089_bib31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.113089_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107774","article-title":"Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2","volume":"31","author":"Peng","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2022.113089_bib33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses - drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Disco"},{"key":"10.1016\/j.biopha.2022.113089_bib34","doi-asserted-by":"crossref","first-page":"11318","DOI":"10.1128\/JVI.01052-08","article-title":"The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles","volume":"82","author":"Siu","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2022.113089_bib35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.113089_bib36","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"China Medical Treatment Expert Group for COVID-19. Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2022.113089_bib37","doi-asserted-by":"crossref","first-page":"2010338","DOI":"10.1080\/19932820.2021.2010338","article-title":"Symptoms at disease onset predict prognosis in COVID-19 disease","volume":"17","author":"Zhou","year":"2022","journal-title":"Libyan J. Med"},{"key":"10.1016\/j.biopha.2022.113089_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijheh.2020.113490","article-title":"First respiratory transmitted food borne outbreak?","volume":"226","author":"Jalava","year":"2020","journal-title":"Int J. Hyg. Environ. Health"},{"key":"10.1016\/j.biopha.2022.113089_bib39","first-page":"11","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil. Med Res"},{"key":"10.1016\/j.biopha.2022.113089_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40249-020-00646-x","article-title":"Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review","volume":"9","author":"Adhikari","year":"2020","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.biopha.2022.113089_bib41","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMc2004973","article-title":"Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1","volume":"382","author":"van Doremalen","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2022.113089_bib42","unstructured":"WHO, Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations: scientific brief, 29 March 2020, World Health Organization. (2020) \u3008https:\/\/www.who.int\/news-room\/commentaries\/detail\/modes-of-transmission-of-virus-causing-COVID-19-implications-for-ipc-precaution-recommendations\u3009 Accessed 15 January 2022."},{"key":"10.1016\/j.biopha.2022.113089_bib43","unstructured":"WHO, Coronavirus disease (COVID-19) technical guidance: laboratory testing for 2019-nCoV in humans. World Health Organization. (2020) \u3008https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/technical-guidance\/laboratory-guidanceAccessed\u3009 15 January 2022."},{"key":"10.1016\/j.biopha.2022.113089_bib44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.amjms.2015.11.011","article-title":"The effect of short-term hyperglycemia on the innate immune system","volume":"351","author":"Jafar","year":"2016","journal-title":"Am. J. Med Sci."},{"key":"10.1016\/j.biopha.2022.113089_bib45","article-title":"Diabetes is a risk factor for the progression and prognosis of COVID-19","volume":"31","author":"Guo","year":"2020","journal-title":"Diabetes Metab. Res Rev."},{"key":"10.1016\/j.biopha.2022.113089_bib46","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1566524053766059","article-title":"Type 2 diabetes: an atherothrombotic syndrome","volume":"5","author":"Dunn","year":"2005","journal-title":"Curr. Mol. Med"},{"key":"10.1016\/j.biopha.2022.113089_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108142","article-title":"COVID-19 and diabetes: Knowledge in progress","volume":"162","author":"Hussain","year":"2020","journal-title":"Diabetes Res Clin. Pr."},{"key":"10.1016\/j.biopha.2022.113089_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms4594","article-title":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections","volume":"5","author":"Zou","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2022.113089_bib49","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/256294","article-title":"Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease","volume":"2012","author":"Tikellis","year":"2012","journal-title":"Int J. Pept."},{"key":"10.1016\/j.biopha.2022.113089_bib50","first-page":"349","article-title":"Cure, Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic","volume":"14","author":"Cure","year":"2020","journal-title":"Diabetes MetabSyndr"},{"key":"10.1016\/j.biopha.2022.113089_bib51","article-title":"COVID-19: Attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism","author":"Wenzhong","year":"2021","journal-title":"ChemRxiv. Camb.: Camb. Open Engag."},{"key":"10.1016\/j.biopha.2022.113089_bib52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13256-020-02659-4","article-title":"COVID-19 and emergencies in patients with diabetes: two case reports","volume":"15","author":"Dey","year":"2021","journal-title":"J. Med Case Rep."},{"key":"10.1016\/j.biopha.2022.113089_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108454","article-title":"Clinical features of patients with type 2 diabetes with and without COVID-19: A case control study (COVIDiab I)","volume":"169","author":"Maddaloni","year":"2020","journal-title":"Diabetes Res Clin. Pr."},{"key":"10.1016\/j.biopha.2022.113089_bib54","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5501\/wjv.v10.i5.275","article-title":"New-onset diabetes in COVID-19 and clinical outcomes: A systematic review and meta-analysis","volume":"10","author":"Shrestha","year":"2021","journal-title":"World J. Virol."},{"key":"10.1016\/j.biopha.2022.113089_bib55","first-page":"3","article-title":"Diabetes and COVID-19: Case study","volume":"10","author":"Fawares","year":"2021","journal-title":"Int Med Case Rep. J."},{"key":"10.1016\/j.biopha.2022.113089_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255144","article-title":"Diabetes increases the risk of COVID-19 in an altitude dependent manner: An analysis of 1,280,806 Mexican patients","volume":"16","author":"Leon-Abarca","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113089_bib57","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fendo.2020.00478","article-title":"Association Between Diabetes and COVID-19: A Retrospective Observational Study With a Large Sample of 1,880 Cases in Leishenshan Hospital, Wuhan","volume":"11","author":"Liu","year":"2020","journal-title":"Front Endocrinol."},{"key":"10.1016\/j.biopha.2022.113089_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108227","article-title":"Association of diabetes mellitus with disease severity and prognosis in COVID-19: A retrospective cohort study","volume":"165","author":"Zhang","year":"2020","journal-title":"Diabetes Res Clin. Pr."},{"key":"10.1016\/j.biopha.2022.113089_bib59","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.dsx.2020.04.044","article-title":"Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis","volume":"14","author":"Kumar","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.biopha.2022.113089_bib60","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","article-title":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China","volume":"109","author":"Li","year":"2020","journal-title":"Clin. Res Cardiol."},{"key":"10.1016\/j.biopha.2022.113089_bib61","doi-asserted-by":"crossref","first-page":"m1966","DOI":"10.1136\/bmj.m1966","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","volume":"369","author":"Petrilli","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.biopha.2022.113089_bib62","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/jmv.25727","article-title":"Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis","volume":"92","author":"Li","year":"2020","journal-title":"J. Med Virol."},{"key":"10.1016\/j.biopha.2022.113089_bib63","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.113089_bib64","doi-asserted-by":"crossref","first-page":"3918723","DOI":"10.1155\/2020\/3918723","article-title":"Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia","volume":"2020","author":"Zhou","year":"2020","journal-title":"J. Diabetes Res"},{"key":"10.1016\/j.biopha.2022.113089_bib65","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes","volume":"31","author":"Zhu","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2022.113089_bib66","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2337\/dc20-0723","article-title":"Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control?","volume":"43","author":"Sardu","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.113089_bib67","article-title":"COVID-19 and diabetes mellitus: unveiling the interaction of two pandemics","volume":"31","author":"Maddaloni","year":"2020","journal-title":"Diabetes Metab. Res Rev."},{"key":"10.1016\/j.biopha.2022.113089_bib68","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001343","article-title":"Clinical characteristics and outcomes of patients with severe COVID-19 with diabetes","volume":"8","author":"Yan","year":"2020","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"10.1016\/j.biopha.2022.113089_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2022.113089_bib70","first-page":"e6","article-title":"Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19","volume":"81","author":"Liu","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.biopha.2022.113089_bib71","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.diabet.2020.05.001","article-title":"Patients with diabetes are at higher risk for severe illness from COVID-19","volume":"46","author":"Targher","year":"2020","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.biopha.2022.113089_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108118","article-title":"Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed","volume":"162","author":"Wang","year":"2020","journal-title":"Diabetes Res Clin. Pr."},{"key":"10.1016\/j.biopha.2022.113089_bib73","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s40261-020-00917-3","article-title":"Rational use of tocilizumab in the treatment of novel coronavirus pneumonia","volume":"40","author":"Zhang","year":"2020","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.biopha.2022.113089_bib74","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1186\/s12879-019-4592-0","article-title":"Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity","volume":"19","author":"Schoen","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.biopha.2022.113089_bib75","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1464-5491.2006.01861.x","article-title":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS","volume":"23","author":"Yang","year":"2006","journal-title":"Diabet. Med"},{"key":"10.1016\/j.biopha.2022.113089_bib76","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12250-015-3679-z","article-title":"Risk factors for severity and mortality in patients with MERS-CoV: Analysis of publicly available data from Saudi Arabia","volume":"31","author":"Banik","year":"2016","journal-title":"Virol. Sin."},{"key":"10.1016\/j.biopha.2022.113089_bib77","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/1753-0407.13036","article-title":"Care for diabetes with COVID-19: advice from China","volume":"12","author":"Wang","year":"2020","journal-title":"J. Diabetes"},{"key":"10.1016\/j.biopha.2022.113089_bib78","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1210\/jc.2018-01168","article-title":"Effect of Hypoglycemia on Inflammatory Responses and the Response to Low-Dose Endotoxemia in Humans","volume":"104","author":"Iqbal","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2022.113089_bib79","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000345107","article-title":"Diabetes and infection: is there a link?--A mini-review","volume":"59","author":"Knapp","year":"2013","journal-title":"Gerontology"},{"key":"10.1016\/j.biopha.2022.113089_bib80","first-page":"575","article-title":"Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms","volume":"34","author":"Petrie","year":"2018","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.biopha.2022.113089_bib81","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1574-695X.1999.tb01397.x","article-title":"Immune dysfunction in patients with diabetes mellitus (DM)","volume":"26","author":"Geerlings","year":"1999","journal-title":"FEMS Immunol. Med Microbiol"},{"key":"10.1016\/j.biopha.2022.113089_bib82","first-page":"187","article-title":"Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections","volume":"18","author":"Moutschen","year":"1992","journal-title":"DiabeteMetab"},{"key":"10.1016\/j.biopha.2022.113089_bib83","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.imbio.2010.06.002","article-title":"High glucose disrupts oligosaccharide recognition function via competitive inhibition: a potential mechanism for immune dysregulation in diabetes mellitus","volume":"216","author":"Ilyas","year":"2011","journal-title":"Immunobiology"},{"key":"10.1016\/j.biopha.2022.113089_bib84","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.virol.2013.06.026","article-title":"Glycolytic control of vacuolar-type ATPase activity: a mechanism to regulate influenza viral infection","volume":"444","author":"Kohio","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.biopha.2022.113089_bib85","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1183\/09031936.97.10081850","article-title":"Alterations of lung structure in experimental diabetes, and diabetes associated with hyperlipidaemia in hamsters","volume":"10","author":"Popov","year":"1997","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biopha.2022.113089_bib86","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1183\/09031936.93.02010014","article-title":"Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study","volume":"2","author":"Lange","year":"1983","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biopha.2022.113089_bib87","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3803\/EnM.2020.35.2.197","article-title":"Encountering COVID-19 as endocrinologists","volume":"35","author":"Rhee","year":"2020","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2022.113089_bib88","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S2213-8587(20)30152-2","article-title":"Practical recommendations for the management of diabetes in patients with COVID-19","volume":"8","author":"Bornstein","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.biopha.2022.113089_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108125","article-title":"COVID-19 and diabetes: Can DPP4 inhibition play a role?","volume":"162","author":"Iacobellis","year":"2020","journal-title":"Diabetes Res Clin. Pr."},{"key":"10.1016\/j.biopha.2022.113089_bib90","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.2337\/dc20-0944","article-title":"Early Observation and Mitigation of Challenges in Diabetes Management of COVID-19 Patients in Critical Care Units","volume":"43","author":"Hamdy","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.113089_bib91","first-page":"241","article-title":"Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes MetabSyndr."},{"key":"10.1016\/j.biopha.2022.113089_bib92","article-title":"Fatal toxicity of chloroquine or hydroxychloroquine with metformin in mice","author":"Rajeshkumar","year":"2020","journal-title":"Biorxiv"},{"key":"10.1016\/j.biopha.2022.113089_bib93","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/1753-0407.13053","article-title":"Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of COVID-19 pandemic","volume":"12","author":"Infante","year":"2020","journal-title":"J. Diabetes"},{"key":"10.1016\/j.biopha.2022.113089_bib94","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12933-020-01047-y","article-title":"Impact of diabetes mellitus on clinical outcomes in patients affected by COVID-19","volume":"19","author":"Sardu","year":"2020","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.biopha.2022.113089_bib95","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.2337\/dc20-S004","article-title":"Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes-2020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.113089_bib96","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2337\/diacare.23.1.95","article-title":"Use of influenza and pneumococcal vaccines in people with diabetes","volume":"23","author":"Smith","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.113089_bib97","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/adc.78.1.54","article-title":"Hyporesponsiveness to intradermal administration of hepatitis B vaccine in insulin dependent diabetes mellitus","volume":"78","author":"Li Volti","year":"1998","journal-title":"Arch. Dis. Child"},{"key":"10.1016\/j.biopha.2022.113089_bib98","doi-asserted-by":"crossref","first-page":"886","DOI":"10.4103\/2230-8210.102982","article-title":"Suggested use of vaccines in diabetes","volume":"16","author":"Kesavadev","year":"2012","journal-title":"Indian J. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2022.113089_bib99","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jama.2012.194","article-title":"Prevention of pneumococcal infection with vaccines: an evolving story","volume":"307","author":"Shapiro","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2022.113089_bib100","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Clinical trial group. safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2022.113089_bib101","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2022.113089_bib102","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Oxford COVID Vaccine Trial Group. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.113089_bib103","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia","volume":"397","author":"Logunov","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.113089_bib104","first-page":"193","article-title":"Impaired anti-SARS-CoV-2 antibody response in non-severe COVID-19 patients with diabetes mellitus: A preliminary report","volume":"15","author":"Pal","year":"2021","journal-title":"Diabetes MetabSyndr."},{"key":"10.1016\/j.biopha.2022.113089_bib105","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1210\/clinem\/dgab055","article-title":"Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia","volume":"106","author":"Dispinseri","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2022.113089_bib106","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1007\/s00125-020-05284-4","article-title":"Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study","volume":"63","author":"Lampasona","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2022.113089_bib107","unstructured":"WHO, Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria\u2122, SII COVISHIELD\u2122). World Health Organization, 2021. \u3008https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-vaccines-SAGE_recommendation-AZD1222\u20132021.1Accessed\u3009 15 January 2022."},{"key":"10.1016\/j.biopha.2022.113089_bib108","first-page":"939","article-title":"Diabetes and COVID-19 infection","volume":"16","author":"Kosinski","year":"2020","journal-title":"Rev. Med."},{"key":"10.1016\/j.biopha.2022.113089_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154245","article-title":"Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next","volume":"107","author":"Angelidi","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2022.113089_bib110","first-page":"13","article-title":"Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers","author":"de Simone","year":"2020","journal-title":"Eur. Soc. Cardiol."},{"key":"10.1016\/j.biopha.2022.113089_bib111","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2337\/dc20-0660","article-title":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication","volume":"43","author":"Chen","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2022.113089_bib112","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1001\/jama.2019.19365","article-title":"Prevalence of diabetes by race and ethnicity in the United States, 2011-2016","volume":"322","author":"Cheng","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2022.113089_bib113","article-title":"Korea National Committee for Clinical Management of COVID-19. Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19","volume":"35","author":"Kim","year":"2020","journal-title":"J. Korean Med Sci."},{"key":"10.1016\/j.biopha.2022.113089_bib114","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131774","article-title":"Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection","volume":"4","author":"Kulcsar","year":"2019","journal-title":"JCI Insight"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222004784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222004784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:01:46Z","timestamp":1787598106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222004784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":114,"alternative-id":["S0753332222004784"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113089","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113089"}}